LONDON (AP) _ Myovant Sciences Ltd. (MYOV) on Wednesday reported a loss of $63.4 million in its fiscal third quarter.

The London-based company said it had a loss of 68 cents per share.

The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 59 cents per share.

The biopharmaceutical company posted revenue of $54.4 million in the period.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MYOV at https://www.zacks.com/ap/MYOV

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News